Literature DB >> 3359738

Intravenous phenytoin loading in patients after neurosurgery and in status epilepticus. A population pharmacokinetic study.

S Vozeh1, T Uematsu, L Aarons, P Maitre, H Landolt, O Gratzl.   

Abstract

In 49 patients treated with intravenous phenytoin after a neurosurgical procedure or because of repetitive frequent seizures, the serum concentration was measured before and 2 hours after an intravenous bolus injection. Based on these data the apparent volume of distribution and intra- and interpatient variability were determined in this representative patient population, using the statistical package NONMEM. From 5 characteristics tested (age, sex, bodyweight, serum albumin, renal function) only bodyweight was found to significantly influence the apparent volume of distribution of phenytoin. The population average was estimated as 1.0 +/- 0.04 L/kg (estimate +/- SE) and interindividual variability, expressed as coefficient of variation, was 23 +/- 6%. By means of Monte Carlo simulations an optimal dosing scheme for phenytoin loading has been calculated. Based on these results, a dose of 15 mg/kg divided into 3 intravenous injections administered 2 hours apart at a maximum rate of 50 mg/min is recommended. This loading regimen should result in therapeutic concentrations (10 to 20 mg/L) in 90% of patients within 6 hours.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3359738     DOI: 10.2165/00003088-198814020-00004

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  17 in total

1.  Estimation of population characteristics of pharmacokinetic parameters from routine clinical data.

Authors:  L B Sheiner; B Rosenberg; V V Marathe
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

2.  General principles of treatment: responsive and intractable status epilepticus in adults.

Authors:  D M Treiman
Journal:  Adv Neurol       Date:  1983

3.  Predicting individual phenytoin dosage.

Authors:  S Vozeh; K T Muir; L B Sheiner; F Follath
Journal:  J Pharmacokinet Biopharm       Date:  1981-04

4.  The clinical pharmacokinetics of phenytoin.

Authors:  E Martin; T N Tozer; L B Sheiner; S Riegelman
Journal:  J Pharmacokinet Biopharm       Date:  1977-12

5.  Steady-state pharmacokinetics of phenytoin from routinely collected patient data.

Authors:  T H Grasela; L B Sheiner; B Rambeck; H E Boenigk; A Dunlop; P W Mullen; J Wadsworth; A Richens; T Ishizaki; K Chiba
Journal:  Clin Pharmacokinet       Date:  1983 Jul-Aug       Impact factor: 6.447

6.  Nomographic estimation of time to reach steady-state serum concentration during phenytoin therapy.

Authors:  S Vozeh; F Follath
Journal:  Eur J Clin Pharmacol       Date:  1980-01       Impact factor: 2.953

7.  Phenytoin disposition in obesity. Determination of loading dose.

Authors:  D R Abernethy; D J Greenblatt
Journal:  Arch Neurol       Date:  1985-05

8.  Phenytoin and postoperative epilepsy. A double-blind study.

Authors:  J B North; R K Penhall; A Hanieh; D B Frewin; W B Taylor
Journal:  J Neurosurg       Date:  1983-05       Impact factor: 5.115

9.  Postoperative epilepsy: a double-blind trial of phenytoin after craniotomy.

Authors:  J B North; R K Penhall; A Hanieh; C S Hann; R G Challen; D B Frewin
Journal:  Lancet       Date:  1980-02-23       Impact factor: 79.321

10.  Which drug for the adult epileptic patient: phenytoin or valproate?

Authors:  D M Turnbull; D Howel; M D Rawlins; D W Chadwick
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-16
View more
  6 in total

Review 1.  Therapeutic drug monitoring of phenytoin. Rationale and current status.

Authors:  M Levine; T Chang
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

2.  Evaluation of population (NONMEM) pharmacokinetic parameter estimates.

Authors:  S Vozeh; P O Maitre; D R Stanski
Journal:  J Pharmacokinet Biopharm       Date:  1990-04

3.  Population pharmacokinetics of quinidine.

Authors:  K Fattinger; S Vozeh; H R Ha; M Borner; F Follath
Journal:  Br J Clin Pharmacol       Date:  1991-03       Impact factor: 4.335

4.  Intravenous phenytoin: a retrospective analysis of Bayesian forecasting versus conventional dosing in patients.

Authors:  Andrea Tobler; Stefan Mühlebach
Journal:  Int J Clin Pharm       Date:  2013-06-29

Review 5.  Lean body mass as a predictor of drug dosage. Implications for drug therapy.

Authors:  D J Morgan; K M Bray
Journal:  Clin Pharmacokinet       Date:  1994-04       Impact factor: 6.447

Review 6.  Pharmacokinetic optimisation of anticonvulsant therapy.

Authors:  A H Thomson; M J Brodie
Journal:  Clin Pharmacokinet       Date:  1992-09       Impact factor: 6.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.